Your browser doesn't support javascript.
loading
Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
Haggerty, Treah; Turiano, Nicholas A; Turner, Tyra; Dekeseredy, Patricia; Sedney, Cara L.
Afiliación
  • Haggerty T; Department of Family Medicine, West Virginia University, 2nd Floor HSS, Morgantown, WV, 26506, USA. haggertyt@hsc.wvu.edu.
  • Turiano NA; Department of Psychology, West Virginia Prevention Research Center, West Virginia University, Morgantown, WV, 26506, USA.
  • Turner T; Health Sciences, West Virginia University, Morgantown, WV, 26506, USA.
  • Dekeseredy P; Department of Neurosurgery, West Virginia University, Morgantown, WV, 26506, USA.
  • Sedney CL; Department of Neurosurgery, West Virginia University, Morgantown, WV, 26506, USA.
Addict Sci Clin Pract ; 17(1): 72, 2022 12 14.
Article en En | MEDLINE | ID: mdl-36517926
ABSTRACT

BACKGROUND:

Medication for opioid use disorder (MOUD) includes administering medications such as buprenorphine or methadone, often with mental health services. MOUD has been shown to significantly improve outcomes and success of recovery from opioid use disorder. In WV, only 18% of providers including physicians, physician assistants, and nurse practitioners are waivered, and 44% of non-waivered providers were not interested in free training even if compensated. This exploratory research seeks to understand intervention-related stigma in community-based primary care providers in rural West Virginia, determine whether financial incentives for training may be linked to levels of stigma, and what level of financial incentives would be required for non-adopters of MOUD services provision to obtain training.

METHOD:

Survey questions were included in the West Virginia Practice-Based Research Network (WVPBRN) annual Collective Outreach & Research Engagement (CORE) Survey and delivered electronically to each practice site in WV. General demographic, staff attitudes and views on compensation for immersion training for delivering MOUD therapy in primary care offices were returned. Statistical analysis included logistic and multinomial logistic regression and an independent samples t-test.

RESULTS:

Data were collected from 102 participants. Perceived stigma did significantly predict having a waiver with every 1-unit increase in stigma being associated with a 65% decreased odds of possessing a waiver for buprenorphine/MOUD (OR = 0.35; 95% CI 0.16-0.78, p = 0.01). Further, t-test analyses suggested there was a statistically significant mean difference in perceived stigma (t(100) = 2.78, p = 0.006) with those possessing a waiver (M = 1.56; SD = 0.51) having a significantly lower perceived stigma than those without a waiver (M = 1.92; SD = 0.57). There was no statistically significant association of stigma on whether someone with a waiver actually prescribed MOUD or not (OR = 0.28; 95% CI 0.04-2.27, p = 0.234).

CONCLUSION:

This survey of rural primary care providers demonstrates that stigmatizing beliefs related to MOUD impact the desired financial incentive to complete a one-day immersion, and that currently unwaivered providers endorse more stigmatizing beliefs about MOUD when compared to currently waivered providers. Furthermore, providers who endorse stigmatizing beliefs with respect to MOUD require higher levels of compensation to consider such training.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Addict Sci Clin Pract Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Addict Sci Clin Pract Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos